Literature DB >> 17468440

Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions.

K Tanaka1, T Tani, M Tanaka, T Saida, J Idezuka, M Yamazaki, M Tsujita, T Nakada, K Sakimura, M Nishizawa.   

Abstract

Multiple sclerosis (MS) in Asian populations is often characterized by the selective involvement of the optic nerve (ON) and spinal cord (SP) (OSMS) in contrast to classic MS (CMS), where frequent lesions are observed in the cerebrum, cerebellum or brainstem. In Western countries, inflammatory demyelinating disease preferentially involving the ON and SP is called neuromyelitis optica (NMO). Recently, Lennon et al. discovered that NMO-IgG, shown to bind to aquaporin 4 (AQP4), could be a specific marker of NMO and also of Japanese OSMS whose clinical features were identical to NMO having long spinal cord lesions extending over three vertebral segments (LCL). To examine this antibody in larger populations of Japanese OSMS patients in order to know its epidemiological and clinical spectra, we established an immunohistochemical detection system for the anti-AQP4 antibody (AQP4-Ab) using the AQP4-transfected human embryonic kidney cell line (HEK-293) and confirmed AQP4-Ab positivity together with the immunohistochemical staining pattern of NMO-IgG in approximately 60% of Japanese OSMS patients with LCL. Patients with OSMS without LCL and those with CMS were negative for this antibody. Our results accorded with those of Lennon et al. suggest that Japanese OSMS with LCL may have an underlying pathogenesis in common with NMO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468440     DOI: 10.1177/1352458507076976

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  14 in total

1.  A case of neuromyelitis optica developing into myelitis 25 years after optic neuritis.

Authors:  Mikihide Ogasawara; Keigo Shikishima; Tsutomu Sakai; Mineo Takagi; Keiko Tanaka
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

2.  Treatment of neuromyelitis optica: current debate.

Authors:  Tomoko Okamoto; Masafumi Ogawa; Youwei Lin; Miho Murata; Sachiko Miyake; Takashi Yamamura
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

3.  Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.

Authors:  Setty M Magaña; Sean J Pittock; Vanda A Lennon; B Mark Keegan; Brian G Weinshenker; Claudia F Lucchinetti
Journal:  Arch Neurol       Date:  2009-08

4.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

5.  Clinical Profile of Anti-Myelin Oligodendrocyte Glycoprotein Antibody Seropositive Cases of Optic Neuritis.

Authors:  Ryusaku Matsuda; Takeshi Kezuka; Akihiko Umazume; Yoko Okunuki; Hiroshi Goto; Keiko Tanaka
Journal:  Neuroophthalmology       Date:  2015-08-25

6.  Reversible stenosis of large cerebral arteries in a patient with combined Sjögren's syndrome and neuromyelitis optica spectrum disorder.

Authors:  Yuichiro Ii; Akihiro Shindo; Ryogen Sasaki; Yutaka Naito; Keiko Tanaka; Shigeki Kuzuhara
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

7.  Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Authors:  Sven Jarius; Klemens Ruprecht; Brigitte Wildemann; Tania Kuempfel; Marius Ringelstein; Christian Geis; Ingo Kleiter; Christoph Kleinschnitz; Achim Berthele; Johannes Brettschneider; Kerstin Hellwig; Bernhard Hemmer; Ralf A Linker; Florian Lauda; Christoph A Mayer; Hayrettin Tumani; Arthur Melms; Corinna Trebst; Martin Stangel; Martin Marziniak; Frank Hoffmann; Sven Schippling; Jürgen H Faiss; Oliver Neuhaus; Barbara Ettrich; Christian Zentner; Kersten Guthke; Ulrich Hofstadt-van Oy; Reinhard Reuss; Hannah Pellkofer; Ulf Ziemann; Peter Kern; Klaus P Wandinger; Florian Then Bergh; Tobias Boettcher; Stefan Langel; Martin Liebetrau; Paulus S Rommer; Sabine Niehaus; Christoph Münch; Alexander Winkelmann; Uwe K Zettl U; Imke Metz; Christian Veauthier; Jörn P Sieb; Christian Wilke; Hans P Hartung; Orhan Aktas; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

8.  Neuromyelitis optica: an antibody-mediated disorder of the central nervous system.

Authors:  Jiwon Oh; Michael Levy
Journal:  Neurol Res Int       Date:  2012-01-29

9.  Genetic and infectious profiles of Japanese multiple sclerosis patients.

Authors:  Satoshi Yoshimura; Noriko Isobe; Tomomi Yonekawa; Takuya Matsushita; Katsuhisa Masaki; Shinya Sato; Yuji Kawano; Ken Yamamoto; Jun-ichi Kira
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

Review 10.  Neuromyelitis optica pathogenesis and aquaporin 4.

Authors:  David J Graber; Michael Levy; Douglas Kerr; William F Wade
Journal:  J Neuroinflammation       Date:  2008-05-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.